| Name | Hope Health And Rehab |
|---|---|
| Location | 438 Ashford Ave, Lomira, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 38 |
| Occupancy Rate | 64.21% |
| Medicare ID (CCN) | 525642 |
| Legal Business Name | Oak Ridge Care Center, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1386644672 |
| Organization Name | OAK RIDGE CARE CENTER, INC. |
| Doing Business As | HOPE HEALTH AND REHABILITATION CENTER |
| Address | 438 Ashford Ave, Lomira, WI 53048 |
| Phone Number | 920-269-4386 |
News Archive
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" payment model for Part B drugs.
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
An international team, led by a University of Adelaide genetics expert, has made a breakthrough discovery which is expected to help thousands of young girls worldwide who are suffering from a rare yet debilitating form of epilepsy.
Immunization for pertussis, also known as whooping cough, began in the mid-1940s and resulted in a sharp decline of this serious illness over the next 25 years. Over the last two decades, however, as immunity has waned, pertussis has re-emerged in the United States, with the greatest increase seen in adolescents, adults and young infants.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" payment model for Part B drugs.
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
An international team, led by a University of Adelaide genetics expert, has made a breakthrough discovery which is expected to help thousands of young girls worldwide who are suffering from a rare yet debilitating form of epilepsy.
Immunization for pertussis, also known as whooping cough, began in the mid-1940s and resulted in a sharp decline of this serious illness over the next 25 years. Over the last two decades, however, as immunity has waned, pertussis has re-emerged in the United States, with the greatest increase seen in adolescents, adults and young infants.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 8.06 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.68 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 68.97 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 15.77 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.9 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 7.53 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.06 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 6.38 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.8 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.04 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.14 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.48 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.17 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 66.9 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.83 | 82.93 |
News Archive
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" payment model for Part B drugs.
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
An international team, led by a University of Adelaide genetics expert, has made a breakthrough discovery which is expected to help thousands of young girls worldwide who are suffering from a rare yet debilitating form of epilepsy.
Immunization for pertussis, also known as whooping cough, began in the mid-1940s and resulted in a sharp decline of this serious illness over the next 25 years. Over the last two decades, however, as immunity has waned, pertussis has re-emerged in the United States, with the greatest increase seen in adolescents, adults and young infants.
› Verified 8 days ago